Abstract
Post-operative venous thromboembolic events (VTE) are a major source of morbidity among patients undergoing oncologic surgery and a leading cause of post-operative deaths.1 Level 1 evidence supports the use of extended post-operative VTE prophylaxis (EP) following major abdominal or pelvic surgery.2 Most commonly, enoxaparin, a low molecular weight heparin is used; however there are numerous barriers including cost, pain, and difficulty with injections which may reduce compliance.3,4
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
